drugset / Trial / NCT02241460

Efficacy of Promescent Lidocaine Spray in Men With Premature Ejaculation

NCT02241460 ↗

Phase 3 Unknown 120 enrolled Eugene Y Rhee, MD
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy of treatment with Promescent Lidocaine Spray compared with placebo in patients with premature ejaculation.

Timeline

Start
2014-03
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 30 mg —
Comparator Lidocaine Other / unclassified 50 mg —
Comparator Lidocaine Other / unclassified 70 mg —

Indications